Departments of Hepatobiliary and Transplant Surgery.
Br J Surg. 2013 Nov;100(12):1627-32. doi: 10.1002/bjs.9285.
Half of patients with colorectal cancer develop liver metastases. There remains great variability between hospitals in rates of liver resection for colorectal cancer liver metastases (CLM). This study aimed to determine how many patients with potentially resectable CLM are not seen by specialist liver surgeons.
Patients presenting with new CLM in a cancer network consisting of a tertiary centre and seven attached hospitals were studied prospectively over 12 months. Data were collected retrospectively for patients who did not have a complete data set. Outcomes for patients referred to the liver tertiary centre were collated. The radiology of tumours deemed inoperable by the local colorectal specialist teams was reviewed by specialist liver surgeons and radiologists.
In total, 631 patients with CLM were assessed. Prospective data were complete for 241 patients, and 64 (26.6 per cent) of these were referred to the specialist liver team for consideration of resection. No decision was documented for 16 patients (6.6 per cent). Of those not referred, 30 (18.6 per cent) were deemed unfit or refused and 131 (81.4 per cent) were thought inoperable. Referral rates varied between hospitals (13-43.6 per cent). Of 131 patients deemed fit but inoperable by the colorectal specialist teams, 38 (29.0 per cent) were deemed operable and 20 (15.3 per cent) had equivocal imaging when assessed retrospectively by liver specialists. In total, 142 of the 631 patients were referred to liver specialists for consideration of treatments, and 107 (75.4 per cent) treated with curative intent.
A considerable number of patients with potentially resectable CLM are not assessed by specialist liver teams. Improved referral rates could greatly improve resection rates for CLM, which may improve outcomes for patients with colorectal cancer.
半数结直肠癌患者会发展为肝转移。不同医院的结直肠癌肝转移(CLM)肝切除术比例存在较大差异。本研究旨在确定有多少潜在可切除 CLM 患者未接受专科肝脏外科医生的评估。
在一个由一家三级中心和七家附属医院组成的癌症网络中,前瞻性研究了 12 个月内新出现 CLM 的患者。对于没有完整数据集的患者,回顾性收集数据。汇总了转诊至肝脏三级中心的患者的结局。由专科肝脏外科医生和放射科医生对当地结直肠专科医生团队认为无法手术的肿瘤的影像学进行评估。
共评估了 631 例 CLM 患者。241 例患者的前瞻性数据完整,其中 64 例(26.6%)被转至专科肝脏团队以考虑行切除术。有 16 例(6.6%)未记录决定。未转诊的患者中,30 例(18.6%)因身体状况不佳或拒绝,131 例(81.4%)被认为无法手术。转诊率在各医院之间存在差异(13-43.6%)。在被结直肠专科医生团队认为适合但无法手术的 131 例患者中,38 例(29.0%)被认为可手术,20 例(15.3%)在由肝脏专科医生回顾性评估时影像学结果不确定。在 631 例患者中,共有 142 例被转诊至肝脏专科医生处以考虑治疗,107 例(75.4%)接受了根治性治疗。
相当数量的潜在可切除 CLM 患者未接受专科肝脏团队的评估。提高转诊率可显著提高 CLM 的切除率,从而可能改善结直肠癌患者的结局。